News: ENTB's BioTech can be Extended to Humans too according to the News Article just posted here!
Stem Cell Research has been in the news this past election season, and Entest is NOT subject to the recent court decisions as the Company has adopted a veterinary first approach, believing once efficacy in animals is established and near term revenue achieved, viability in transitioning to human applications can be made via joint ventures and license agreements.